GB201404987D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201404987D0
GB201404987D0 GB201404987A GB201404987A GB201404987D0 GB 201404987 D0 GB201404987 D0 GB 201404987D0 GB 201404987 A GB201404987 A GB 201404987A GB 201404987 A GB201404987 A GB 201404987A GB 201404987 D0 GB201404987 D0 GB 201404987D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201404987A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharna PLC
Original Assignee
Redx Pharna PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharna PLC filed Critical Redx Pharna PLC
Priority to GB201404987A priority Critical patent/GB201404987D0/en
Publication of GB201404987D0 publication Critical patent/GB201404987D0/en
Priority to PCT/GB2015/050819 priority patent/WO2015140566A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GB201404987A 2014-03-20 2014-03-20 Compounds Ceased GB201404987D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201404987A GB201404987D0 (en) 2014-03-20 2014-03-20 Compounds
PCT/GB2015/050819 WO2015140566A1 (en) 2014-03-20 2015-03-19 Pyrazolo-pyrimidines as inhibitors of btk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201404987A GB201404987D0 (en) 2014-03-20 2014-03-20 Compounds

Publications (1)

Publication Number Publication Date
GB201404987D0 true GB201404987D0 (en) 2014-05-07

Family

ID=50686594

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201404987A Ceased GB201404987D0 (en) 2014-03-20 2014-03-20 Compounds

Country Status (2)

Country Link
GB (1) GB201404987D0 (en)
WO (1) WO2015140566A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016005199B1 (en) 2013-08-23 2022-02-22 Neupharma, Inc CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS, AND METHODS
GB201410430D0 (en) 2014-06-11 2014-07-23 Redx Pharma Ltd Compounds
EA201890730A1 (en) 2015-09-16 2018-10-31 Локсо Онколоджи, Инк. DERIVATIVES OF PYRAZOLOPYRIMIDINE AS BTK INHIBITORS FOR THE TREATMENT OF MALIGNANT NORODUCTURE
KR20180073599A (en) * 2015-11-04 2018-07-02 메르크 파텐트 게엠베하 Methods for treating cancer using pyrimidine and pyridine compounds having BTK inhibitory activity
PE20220502A1 (en) 2015-12-16 2022-04-07 Loxo Oncology Inc COMPOUNDS USEFUL AS KINASE INHIBITORS
WO2017163078A1 (en) 2016-03-24 2017-09-28 Mission Therapeutics Limited 1-cyano-pyrrolidine derivatives as dbu inhibitors
JP7101165B2 (en) * 2016-08-15 2022-07-14 ニューファーマ， インコーポレイテッド Specific chemical entities, compositions, and methods
GB201616627D0 (en) 2016-09-30 2016-11-16 Mission Therapeutics Limited Novel compounds
WO2019130229A1 (en) * 2017-12-28 2019-07-04 Mylan Laboratories Ltd Methods and intermediates for preparing rucaparib
WO2022140246A1 (en) 2020-12-21 2022-06-30 Hangzhou Jijing Pharmaceutical Technology Limited Methods and compounds for targeted autophagy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2530083T1 (en) * 2006-09-22 2016-09-30 Pharmacyclics Llc Inhibitors of bruton's tyrosine kinase
US9376438B2 (en) * 2011-05-17 2016-06-28 Principia Biopharma, Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors

Also Published As

Publication number Publication date
WO2015140566A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
HRP20181797T1 (en) Aminopyridyloxypyrazole compounds
GB201415573D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201411418D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201417369D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201406591D0 (en) Compounds
GB201419228D0 (en) Compounds
GB201406956D0 (en) Compounds
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201419264D0 (en) Compounds
GB201412660D0 (en) Compounds
GB201504956D0 (en) Compounds
GB201419015D0 (en) Compounds
GB201407695D0 (en) Compounds
GB201405361D0 (en) Compounds
GB201707536D0 (en) Compounds
GB201421711D0 (en) Compounds
GB201421019D0 (en) Compounds
GB201421020D0 (en) Compounds
GB201420593D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)